{"acute disseminated encephalomyelitis": 2.47, "adverse reaction": 3.4, "allodynia": 4.47, "areflexia": 3.55, "bedridden": 7.05, "bell's palsy": 4.1, "blister": 14.62, "burning sensation": 3.31, "cellulitis": 4.34, "coronavirus infection": 3.05, "deafness unilateral": 2.02, "demyelinating polyneuropathy": 5.02, "demyelination": 2.22, "dermatitis bullous": 2.77, "diplegia": 2.0, "discomfort": 2.52, "disease prodromal stage": 197.59, "dysaesthesia": 2.33, "encephalitis": 2.99, "erythema": 4.54, "erythema of eyelid": 2.24, "extra dose administered": 5.18, "facial pain": 3.73, "facial paralysis": 2.08, "genital herpes": 3.0, "genital herpes zoster": 17.83, "genital rash": 6.04, "giant cell arteritis": 2.25, "groin pain": 2.05, "guillain-barre syndrome": 9.12, "herpes ophthalmic": 13.21, "herpes simplex": 7.81, "herpes virus infection": 6.29, "herpes zoster": 30.55, "herpes zoster cutaneous disseminated": 26.31, "herpes zoster disseminated": 7.49, "herpes zoster oticus": 22.41, "herpes zoster reactivation": 17.31, "hyperaesthesia": 8.15, "hyporeflexia": 2.37, "immobile": 5.27, "impaired driving ability": 2.23, "inappropriate schedule of product administration": 2.17, "incomplete course of vaccination": 68.99, "incorrect route of product administration": 6.06, "induration": 4.82, "injected limb mobility decreased": 5.76, "injection site cellulitis": 5.88, "injection site discolouration": 3.92, "injection site erythema": 3.48, "injection site paraesthesia": 2.16, "injection site rash": 4.08, "injection site swelling": 2.24, "injection site vesicles": 13.65, "lip blister": 8.09, "local reaction": 11.8, "loss of personal independence in daily activities": 3.41, "lyme disease": 2.48, "lymphangitis": 4.13, "mobility decreased": 3.6, "monoplegia": 2.77, "myelitis transverse": 2.6, "near death experience": 3.21, "nerve injury": 4.14, "neuralgia": 7.52, "neuralgic amyotrophy": 3.74, "neuritis": 4.12, "ophthalmic herpes simplex": 17.58, "ophthalmic herpes zoster": 28.41, "oral herpes": 7.13, "oral mucosal blistering": 4.11, "pain": 2.85, "pain in extremity": 2.14, "pain of skin": 5.97, "paralysis": 2.64, "peripheral swelling": 2.13, "peripheral vascular disorder": 3.1, "polymyalgia rheumatica": 3.59, "post herpetic neuralgia": 30.85, "product administered at inappropriate site": 5.49, "product administered to patient of inappropriate age": 21.23, "product administration error": 2.27, "product complaint": 2.03, "product supply issue": 14.72, "pruritus": 2.74, "pustule": 7.9, "radiculopathy": 2.92, "rash": 3.14, "rash erythematous": 2.48, "rash macular": 2.14, "rash papular": 3.38, "rash pruritic": 2.67, "rash pustular": 7.3, "rash vesicular": 42.18, "scab": 9.39, "scar": 5.08, "skin irritation": 2.21, "skin lesion": 4.5, "skin warm": 6.27, "social problem": 6.73, "swelling": 2.55, "trigeminal neuralgia": 3.31, "vaccination failure": 4.94, "vaccination site inflammation": 3.55, "vaccination site joint swelling": 2.3, "vaccination site warmth": 2.26, "varicella": 9.99, "varicella zoster virus infection": 9.9, "walking aid user": 2.49}